Abbott
Pharma creates non-profit R&D organisation
September 21, 2012Research and Development, Sales and Marketing Abbott, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Co, GlaxoSmithKline, Johnson & Johnson, Pfizer, R&D, Roche Genentech, Sanofi, TransCelerate BioPharma, biopharma
Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …
Humira powers ahead as Abbott prepares split
July 19, 2012Sales and Marketing AbbVie, Abbott, Humira, RA
Humira maintained its rapid growth in the second quarter, helping keep Abbott buoyant ahead of its split into two separate …
AstraZeneca buys Ardea Biosciences
June 22, 2012Research and Development, Sales and Marketing Abbott, Ardea Biosciences, AstraZeneca, Bayer, Humira, Takeda
AstraZeneca has completed its acquisition of US firm Ardea Biosciences in a $1.26 billion deal that it hopes will shore …
Analysts want AstraZeneca-AbbVie tie-up
June 20, 2012Sales and Marketing AbbVie, Abbott, AstraZeneca, merger
Analysts want Abbott’s new spin-off firm AbbVie to merge with the troubled AstraZeneca, saying it could give both firms future …
Abbott sets out AbbVie stall for shareholders
June 12, 2012Manufacturing and Production AbbVie, Abbott, CRO, Taylor, manufacturing
Abbott Laboratories has issued the prospectus for its planned separation of its pharmaceutical operations into a standalone company called AbbVie …
Abbott pays $1.6 billion to settle Depakote claims
May 8, 2012Medical Communications, Sales and Marketing AbbVie, Abbott, CIA, Depakote
Abbott will pay $1.6 billion to settle US legal claims over its epilepsy drug Depakote. The $1.6 billion will settle …
Abbott launches online tool for ankylosing spondylitis
April 23, 2012Medical Communications AS, Abbott, NHS, NICE, ankylosing spondylitis
Abbott has launched a new online assessment tool that has the potential to change the landscape of ankylosing spondylitis (AS) …
Piramal opens ADC plant in Scotland
April 2, 2012Manufacturing and Production ADC, Abbott, Piramel
India’s Piramal Healthcare has officially opened a new production unit to make antibody-drug conjugates at its facility in Grangemouth, Scotland. …
Abbott selects ‘AbbVie’ as new name for R&D firm
March 21, 2012Research and Development, Sales and Marketing Abbott
Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …
Abbott buys into Galapagos’ RA candidate
February 29, 2012Research and Development, Sales and Marketing Abbott, Galapagos, Humira, JAK, RA, TNF
Abbott has struck a deal with Galapagos to develop and commercialise a promising oral JAK1 inhibitor to treat multiple autoimmune …
Lilly plans €330m biomanufacturing plant in Ireland
February 28, 2012Manufacturing and Production Abbott, Ireland, Kinsale, lilly
There was more good news for Ireland’s pharmaceutical sector this week with the announcement by Eli Lilly that it will …
Abbott slashes 700 jobs
January 31, 2012Manufacturing and Production, Sales and Marketing Abbott, FDA, manufacturing
Abbott Laboratories has said it will cut 700 jobs across its US and Puerto Rican operations, including hundreds of manufacturing …
Abbott strong as it prepares for spin-out
January 26, 2012Sales and Marketing Abbott, GAAP, Humira
Abbott enjoyed a strong 2011 thanks to Humira and emerging market growth, with overall worldwide sales rising by 4.1 per …
Vertex chief to step down; names Jeffrey Leiden as new leader
December 19, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex
Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …
Abbott signs $400 million deal with Reata
December 13, 2011Research and Development, Sales and Marketing Abbott
Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …
Latest content
